The loss is on account of reduction in loan burden by early repayment of Loan. However there are pressures on margin as well. One thing which i cannot understand is that the receivable are on 45 crores as against payable which are Rs 98 crores. It might be due to Inventory accumulation and lack of Demand pressure on company leading to compiling of stock. If the same situation continues they cannot even meet out there guidance of crossing 464 crore mark. As of now i have exited my position from stock booked a loss of Rs 6 per share and shifted my position to new company Medicamen Biotech.